1 - 25 of
34
results
for author:"Montgomery K."
in Literature Citations
| Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. Espinosa I., Beck A.H., Lee C.H., Zhu S., Montgomery K.D., Marinelli R.J., Ganjoo K.N., Nielsen T.O., Gilks C.B., West R.B. et al. Am. J. Pathol. 174:2347-2356(2009) · Mapped (4) |
| Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue. Jensen K.C., Schaeffer D.F., Cheang M., Montgomery K., West R.B., Gilks C.B., Ross D., Turashvili G., Schnitt S., van de Rijn M. Mod. Pathol. 21:1413-1420(2008) · Mapped (3) |
| Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Heerema-McKenney A., Wijnaendts L.C., Pulliam J.F., Lopez-Terrada D., McKenney J.K., Zhu S., Montgomery K., Mitchell J., Marinelli R.J., Hart A.A. et al. Am. J. Surg. Pathol. 32:1513-1522(2008) · Mapped (2) |
| Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS. Meisler M.H., Russ C., Montgomery K.T., Greenway M., Ennis S., Hardiman O., Figlewicz D.A., Quenneville N.R., Conibear E., Brown R.H. Jr. Amyotroph Lateral Scler 9:141-148(2008) · Mapped (3) |
| Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. Kwei K.A., Bashyam M.D., Kao J., Ratheesh R., Reddy E.C., Kim Y.H., Montgomery K., Giacomini C.P., Choi Y.L., Chatterjee S. et al. PLoS Genet. 4:e1000081-e1000081(2008) · Mapped (3) |
| Prognostic significance of macrophage infiltration in leiomyosarcomas. Lee C.H., Espinosa I., Vrijaldenhoven S., Subramanian S., Montgomery K.D., Zhu S., Marinelli R.J., Peterse J.L., Poulin N., Nielsen T.O. et al. Clin. Cancer Res. 14:1423-1430(2008) · Mapped (4) |
| hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Lapointe J., Malhotra S., Higgins J.P., Bair E., Thompson M., Salari K., Giacomini C.P., Ferrari M., Montgomery K., Tibshirani R. et al. Am. J. Surg. Pathol. 32:205-209(2008) · Mapped (2) |
| Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Lee C.H., Espinosa I., Jensen K.C., Subramanian S., Zhu S.X., Varma S., Montgomery K.D., Nielsen T.O., van de Rijn M., West R.B. Mod. Pathol. 21:531-539(2008) · Mapped (4) |
| SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients. Swanson K.D., Winter J.M., Reis M., Bentires-Alj M., Greulich H., Grewal R., Hruban R.H., Yeo C.J., Yassin Y., Iartchouk O. et al. Genes Chromosomes Cancer 47:253-259(2008) · Mapped (6) |
| The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. Jensen K.C., Higgins J.P., Montgomery K., Kaygusuz G., van de Rijn M., Natkunam Y. Mod. Pathol. 20:871-877(2007) · Mapped (23) |
| Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Roberts A.E., Araki T., Swanson K.D., Montgomery K.T., Schiripo T.A., Joshi V.A., Li L., Yassin Y., Tamburino A.M., Neel B.G. et al. |
| Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S., Diggins L.T., He J., Saucier M., Deziel E. et al. Genome Biol. 7:R90.1-R90.14(2006) · UniProtKB (5,886) |
| Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Sneddon J.B., Zhen H.H., Montgomery K., van de Rijn M., Tward A.D., West R., Gladstone H., Chang H.Y., Morganroth G.S., Oro A.E. et al. Proc. Natl. Acad. Sci. U.S.A. 103:14842-14847(2006) · Mapped (8) |
| Upregulation of histidine decarboxylase expression in superficial cortical nephrons during pregnancy in mice and women. Morgan T.K., Montgomery K., Mason V., West R.B., Wang L., van de Rijn M., Higgins J.P. Kidney Int. 70:306-314(2006) · Mapped (2) |
| The finished DNA sequence of human chromosome 12. Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A. et al. Nature 440:346-351(2006) · UniProtKB (660) |
| Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse. Moran J.L., Bolton A.D., Tran P.V., Brown A., Dwyer N.D., Manning D.K., Bjork B.C., Li C., Montgomery K., Siepka S.M. et al. Genome Res. 16:436-440(2006) · Mapped (23) |
| A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. West R.B., Rubin B.P., Miller M.A., Subramanian S., Kaygusuz G., Montgomery K., Zhu S., Marinelli R.J., De Luca A., Downs-Kelly E. et al. Proc. Natl. Acad. Sci. U.S.A. 103:690-695(2006) · Mapped (4) |
| Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Phillips W.A., Russell S.E., Ciavarella M.L., Choong D.Y., Montgomery K.G., Smith K., Pearson R.B., Thomas R.J., Campbell I.G. Int. J. Cancer 118:2644-2646(2006) · Mapped (6) |
| The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women. Montgomery K.G., Chang J.H., Gertig D.M., Dite G.S., McCredie M.R., Giles G.G., Southey M.C., Hopper J.L., Campbell I.G. Breast Cancer Res. 7:R353-6(2005) · Mapped (8) |
| Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Dziejman M., Serruto D., Tam V.C., Sturtevant D., Diraphat P., Faruque S.M., Rahman M.H., Heidelberg J.F., Decker J., Li L. et al. Proc. Natl. Acad. Sci. U.S.A. 102:3465-3470(2005) · UniProtKB (28) |
| Mutation of the PIK3CA gene in ovarian and breast cancer. Campbell I.G., Russell S.E., Choong D.Y.H., Montgomery K.G., Ciavarella M.L., Hooi C.S.F., Cristiano B.E., Pearson R.B., Phillips W.A. Cancer Res. 64:7678-7681(2004) · UniProtKB (1) |
| Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles. Subramanian S., West R.B., Corless C.L., Ou W., Rubin B.P., Chu K.M., Leung S.Y., Yuen S.T., Zhu S., Hernandez-Boussard T. et al. Oncogene 23:7780-7790(2004) · Mapped (8) |
| The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Montgomery K.G., Liu M.C., Eccles D.M., Campbell I.G. Breast Cancer Res. 6:R390-4(2004) · Mapped (9) |
| The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R. et al. Am. J. Pathol. 165:107-113(2004) · UniProtKB (1) |
| The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Montgomery K.G., Gertig D.M., Baxter S.W., Milne R.L., Dite G.S., McCredie M.R., Giles G.G., Southey M.C., Hopper J.L., Campbell I.G. Cancer Epidemiol. Biomarkers Prev. 12:1109-1111(2003) · Mapped (8) |
